Compounds > 4-n-pyrrolidinylazobenzene
Page last updated: 2024-09-24

4-n-pyrrolidinylazobenzene

Description

4-N-pyrrolidinylazobenzene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID114785
SCHEMBL ID7764536
SCHEMBL ID10343353
MeSH IDM0099756

Synonyms (13)

Synonym
1-(p-(phenylazo)phenyl)pyrrolidine
4-n-pyrrolidinylazobenzene
brn 0220377
1-(4-(phenylazo)phenyl)pyrrolidine
pyrrolidine, 1-(4-(phenylazo)phenyl)-
pyrrolidine, 1-(p-(phenylazo)phenyl)-
phenyl-(4-pyrrolidin-1-ylphenyl)diazene
5-20-01-00446 (beilstein handbook reference)
10282-34-5
SCHEMBL7764536
SCHEMBL10343353
DTXSID101037742
pyrrolidine, 1-[4-(2-phenyldiazenyl)phenyl]-

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
5-dimethylaminophenylazoindazole[no description available]medium10
methyldimethylaminoazobenzene[no description available]medium20
n,n-dimethyl-4-(6-benzothiazolylazo)aniline[no description available]medium10
p-dimethylaminoazobenzene[no description available]medium30azobenzenes
thiazoles[no description available]medium101,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
ConditionIndicatedRelationship StrengthStudiesTrials
Cancer of Liver0low10
Cancer of the Liver0low10
Cancer, Hepatocellular0low10
Cocarcinogenesis0low10
Condition, Preneoplastic0low10
Conditions, Preneoplastic0low10
Experimental Hepatoma0low20
Experimental Hepatomas0low20
Experimental Liver Neoplasms0low20
Experimental Neoplasms0low10
Hepatic Cancer0low10
Hepatic Neoplasms0low10
Hepatocellular Cancer0low10
Hepatoma, Experimental0low20
Hepatoma, Morris0low20
Hepatoma, Novikoff0low20
Hepatomas, Experimental0low20
Liver Cancer0low10
Liver Neoplasms0low10
Liver Neoplasms, Experimental0low20
Neoplasms, Experimental0low10
Neoplasms, Experimental Liver0low20
Neoplasms, Hepatic0low10
Neoplasms, Liver0low10
Precancerous Conditions0low10
Preneoplastic Condition0low10
Preneoplastic Conditions0low10

Research Highlights

Dosage (1)

ArticleYear
Studies in vivo to investigate the status of 4-N-pyrrolidinylazobenzene as a pure cancer initiating agent to the rat liver.
Cancer letters, Volume: 27, Issue: 1		1985
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]